Literature DB >> 32947546

Patients' perceptions of the pathways linking chronic pain with problematic substance use.

Jessica J Wyse1,2, Jennette Lovejoy3, Julia Holloway4, Benjamin J Morasco2,5, Steven K Dobscha2,5, Hildi Hagedorn6,7, Travis I Lovejoy2,5.   

Abstract

ABSTRACT: Approximately one-half of patients with substance use disorders (SUDs) experience chronic pain. Yet, how patients perceive the relationship between their substance use and chronic pain remains poorly understood. We sought to identify how patients with comorbid SUD and chronic pain describe the relationship between, and mechanisms linking, these conditions. We conducted qualitative interviews with 34 patients engaged in SUD treatment who were also diagnosed with chronic pain. Interviews were transcribed verbatim and coded by both primary and secondary coders. Qualitative content analysis guided coding and analysis. Patient interviews revealed 3 primary pathways. One group of participants described SUD as developing independently from their experiences of chronic pain. A second group of participants described turning to substances to self-manage or cope with the physical and emotional aspects of chronic pain. A third group of participants described encounters with opioid medications as the causal agent initiating a SUD. Our findings build on research that has identified chronic pain and SUD as developmentally similar and mutually reinforcing, by revealing the ways in which patients themselves understand and experience the interconnections between their substance use and chronic pain.
Copyright © 2020 International Association for the Study of Pain.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 32947546      PMCID: PMC7886942          DOI: 10.1097/j.pain.0000000000002077

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   7.926


  19 in total

1.  Three approaches to qualitative content analysis.

Authors:  Hsiu-Fang Hsieh; Sarah E Shannon
Journal:  Qual Health Res       Date:  2005-11

2.  Methadone maintenance and the cost and utilization of health care among individuals dependent on opioids in a commercial health plan.

Authors:  Dennis McCarty; Nancy A Perrin; Carla A Green; Michael R Polen; Michael C Leo; Frances Lynch
Journal:  Drug Alcohol Depend       Date:  2010-10-01       Impact factor: 4.492

Review 3.  Alcohol dependence as a chronic pain disorder.

Authors:  Mark Egli; George F Koob; Scott Edwards
Journal:  Neurosci Biobehav Rev       Date:  2012-09-11       Impact factor: 8.989

Review 4.  Opioid Abuse in Chronic Pain--Misconceptions and Mitigation Strategies.

Authors:  Nora D Volkow; A Thomas McLellan
Journal:  N Engl J Med       Date:  2016-03-31       Impact factor: 91.245

5.  A randomized trial of a pain management intervention for adults receiving substance use disorder treatment.

Authors:  Mark A Ilgen; Amy S B Bohnert; Stephen Chermack; Carly Conran; Mary Jannausch; Jodie Trafton; Frederic C Blow
Journal:  Addiction       Date:  2016-04-15       Impact factor: 6.526

6.  Chronic pain among patients with opioid use disorder: Results from electronic health records data.

Authors:  Yih-Ing Hser; Larissa J Mooney; Andrew J Saxon; Karen Miotto; Douglas S Bell; David Huang
Journal:  J Subst Abuse Treat       Date:  2017-03-09

Review 7.  Pain and the brain: specificity and plasticity of the brain in clinical chronic pain.

Authors:  Vania A Apkarian; Javeria A Hashmi; Marwan N Baliki
Journal:  Pain       Date:  2010-12-13       Impact factor: 6.961

Review 8.  Common Brain Mechanisms of Chronic Pain and Addiction.

Authors:  Igor Elman; David Borsook
Journal:  Neuron       Date:  2016-01-06       Impact factor: 17.173

Review 9.  Reward, motivation, and emotion of pain and its relief.

Authors:  Frank Porreca; Edita Navratilova
Journal:  Pain       Date:  2017-04       Impact factor: 7.926

Review 10.  CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.

Authors:  Deborah Dowell; Tamara M Haegerich; Roger Chou
Journal:  JAMA       Date:  2016-04-19       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.